NOP53 and Alzheimer disease: Based on the current results, we propose that the accumulated ambient glutamate caused by GLT blockade promotes the tonic NMDAR activity at the soma and in turn triggers a novel somatic amplification mechanism that accounts for the neuronal hyperactivity initiated by impaired glutamate reuptake in AD.